MỘT SỐ KẾT QUẢ HOẠT ĐỘNG KINH DOANH CỦA CHUỖI NHÀ THUỐC MỸ ĐẠT TẠI THÀNH PHỐ HÀ NỘI NĂM 2021

Abstract

Objective: Analyzing business performance of My Dat pharmacy chain in Hanoi in 2021. Subject: Business performance of pharmacy chain through results in financial statements of My Dat pharmacy chain from 1 January 2021 to 31 December 2021. Methods: Cross-sectional descriptiVe study, retrospectiVely reView of all business results that occurred in 2021 of My Dat pharmacy chain. Result: The reVenue reached VND 18,366 million; and the total cost of business actiVities was 1,340 million VND/year, including: Variable costs accounted for 95.8%, fixed costs accounted for 4.2%; gross profit margin (LNG) reached 3,420 million VND, LNG reached 18.6%; net profit reached 2,078 million VND, ROS reached 11.3%. The reVenue and profit margin of actual prescription drugs reached VND 816 million (15.8%), with the gross profit margin of 15.1%. OVer- the-counter prescription drugs accounted for 84.2% of total reVenue and achieVed an LNG of 35.9%. The number of customers at the pharmacy chain reached 87,934 people/year, 244 people/day, with the aVerage payment of 606,000 VND/purchase. Meanwhile, 240 customers did not buy drugs, 144 customers returned the products, and 12 customers proVided feedback on the drugs purchased. Conclusion: The business performance of My Dat pharmacy chain in 2021 are quite high compared to other pharmacies in the domestic market with a reVenue of VND 18,366 million, reaching an LNG ratio of 18.6% and a net profit margin (ROS) of 11.3%.